chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; diarrhea; tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 72 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Jul2021 (Lot number: ER8731) at the age of 72 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Hepatitis vaccine (about 10 years ago, allergic reaction), reaction(s): "allergic reaction". The following information was reported: HEADACHE (non-serious) with onset 01Jul2021, outcome "recovered" (Aug2021), described as "headache"; DIARRHOEA (non-serious) with onset Jul2021, outcome "recovered" (Aug2021), described as "diarrhea"; FATIGUE (non-serious) with onset Jul2021, outcome "recovered" (Aug2021), described as "tiredness".  Additional Information: It was reported that, patient who received Pfizer COVID-19 vaccine first dose 01Jul2021 and had an allergic reaction of headache, diarrhea, and tiredness that lasted 6 weeks. Reports caller missed her second dose, so she was asking if she can get her second dose received now or if she has to start over again to get the second dose. Agent reports caller also reported having an allergic reaction to a different vaccine and having proceeded to get the first COVID-19 vaccine. Says her headache started the day she got the first dose of the Pfizer COVID-19 vaccine, and it was just kind of like when you have the flu where you feel run down and your stomach was upset and you have diarrhea and it goes away. She says it was a rotating thing, so she would feel nauseated one day then it goes away, then a couple days later she would have diarrhea that went away, kind of in a circle. She says for a couple days she had diarrhea and a really bad headache. She says it seemed like every day it was something. Says that she had side effects or adverse reaction to a vaccine in the past, and had to go to the hospital, and this time she just had side effects that lasted a long time. She says but since it lasted so long when she was supposed to get the second dose in 3 weeks she didnt go back, so she wanted to know if she could get the second dose still or if she needed to start over on getting the Pfizer COVID-19 vaccine. Says she was advised if she got it and had side effects to just go to the hospital, but that it would be better to get the Pfizer COVID-19 vaccine now. Says she had side effects for so long but she does want to be fully protected.   No follow-up attempts are possible. No further information is expected.
A 2 year old died from a single Pfizer COVID shot after 6 hours the same day,and the CDC tried to hide it:; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570).  A 2-year-old patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) at the age of 2 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), 6 hrs after the suspect product(s) administration, outcome "fatal", described as "A 2 year old died from a single Pfizer COVID shot after 6 hours the same day,and the CDC tried to hide it:". The date and cause of death for the patient were unknown. It was unknown if an autopsy was performed.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: Unknown cause of death
Itchy; Rash all over his body; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (Itchy) and RASH (Rash all over his body) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported. No concomitant medication was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PRURITUS (Itchy) and RASH (Rash all over his body). At the time of the report, PRURITUS (Itchy) and RASH (Rash all over his body) outcome was unknown.      Treatment medication included Topical Lotions.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
pain in hands, and cheeks; pain went down to shoulders; pain in both sides of her neck, pain went down to shoulders, hands, and cheeks; feeling congested; This spontaneous case was reported by a patient and describes the occurrence of NECK PAIN (pain in both sides of her neck, pain went down to shoulders, hands, and cheeks), FEELING ABNORMAL (feeling congested), MYALGIA (pain in hands, and cheeks) and ARTHRALGIA (pain went down to shoulders) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033CZA) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia.    On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced NECK PAIN (pain in both sides of her neck, pain went down to shoulders, hands, and cheeks) and FEELING ABNORMAL (feeling congested). On an unknown date, the patient experienced MYALGIA (pain in hands, and cheeks) and ARTHRALGIA (pain went down to shoulders). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NECK PAIN (pain in both sides of her neck, pain went down to shoulders, hands, and cheeks), FEELING ABNORMAL (feeling congested), MYALGIA (pain in hands, and cheeks) and ARTHRALGIA (pain went down to shoulders) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medicines were not provided  Action taken with mRNA-1273 in response to the event was unknown   Reporter did not allow further contact
Pt stated he felt dizzy, and felt like he was going to pass out.   Pt was given water and observed,  EMS was called.
Case number PHEH2012US023559 is an initial spontaneous report received from a consumer on 28 Nov 2012: This report refers to a female patient of unknown age group. She was vaccinated with FLUVIRIN (batch number: 1200501 and expiry date: Jun 2013) intramuscularly into the left arm at a dose of 0.5 ml on 01 Oct 2012. On 02 Oct 2012, she experienced a locked arm with crippling pain that had limited movement of her left arm for 30 days. She presented with inability to sleep for one month because the pain was bothersome, she was unable to put on sleeves when dressing, she had to use her right arm/hand to move her left arm and she was unable to lift and hold items with her left arm. One month after the pain started, she went to a clinic where the physician suggested that she had experienced a rotary cuff injury; however she denied the claim. She had reported this incident to the Vaccine Adverse Event Reporting System (VAERS). Although the intensity of the pain had subsided significantly there was residual pain and discomfort with the movement of her left arm that still persisted. No further information was available.
Had L leg numbness on 2/24 that progressed to her L arm and L head in a week. With subsequent double vision. Found to have multiple enhancing and FLAIR hyperintense lesions in her medulla, L temporal, L frontal and R temporal lobe. She was started on high dose steroids for treatment.
1/14/2023 this started with congestion, sore throat and fever peaking at 101.4. 1/15 tested with an at home COVID-19 test, positive. 1/16 televisit with doctor, who prescribed PAXLOVID, and to treat symptomatically. About 24 hours later, symptoms were a little diminished with fever being reduced. Symptoms gradually diminished over the next few days with symptoms feeling better by the fourth day of taking PAXLOVID. Very bad taste in mouth was experienced at this time. After about a week total, I felt recovered by 1/22. Nasal congestion lingered until 1/24. Fatigue lingered until the beginning of February 2023.
pain at injection site that radiated down left arm then turned into overall body aches on 1/3 at time of injection.    Nausea started on 1/4 around 930am.  overall fatigue
Erythematous lesions over trunk, scalp some more vesicular. Dx varicella, Tx;Symptomatic
Red, swollen, hot to touch (Rt) deltoid. Deltoid measures 11.5 inches across the swollen part of arm. Pt will ice take ibuprofen q6hrs.
Few small red blotches; Red spots on the torso front.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH MACULAR (Few small red blotches) and RASH ERYTHEMATOUS (Red spots on the torso front.) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (reactions include hives, throat tightening), Sulfonamide allergy (sulfa drugs reactions include throat tightening), Drug allergy (Most Anti-inflammatories), Fruit allergy (Kiwi fruit reactions include hives, throat tightening), Drug allergy (Kafflex reactions include throat tightening) and Urticaria. Concomitant products included METOPROLOL TARTRATE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 09-Feb-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red spots on the torso front.). On 02-Mar-2021, the patient experienced RASH MACULAR (Few small red blotches). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Few small red blotches) and RASH ERYTHEMATOUS (Red spots on the torso front.) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       This case was linked toMOD-2021-068561 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Patient details updated On 14-Jun-2021: Patient demographics were updated,Medical history includes Allergies were updated,Concomitant product information was updated Event Red spots on torso outcome was updated from Unknown to Not recovered On 22-Jun-2021: Follow-up information received on 22-Jun-2021 contains no new information On 22-Jun-2021: Follow-up information received on 22-Jun-2021 contains no significant information On 22-Jun-2021: Medical history added, date of lab data updated
This spontaneous report was received from a social media via company representative regarding a female patients of unknown age. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown dates, the patients were vaccinated with GARDASIL, (dose, route, anatomical location, lot number and expiration date were not reported) for prophylaxis. It was reported that on unspecified date, the patients had become disabled (adverse event). Additionally it stated that the pharmaceutical companies which made the GARDASIL, as well as the Department of Health and Human Services which hold patents and earns profits from the GARDASIL said that they were all coincidence also that the mainstream media denied that these events were even happened. The relatedness between the event and therapy with GARDASIL was not reported. Upon internal review, disability was determined to be medically significant event. The patients had become disabled(adverse event ) was considered to be disabling by the reporter. This is one of several reports from the same source. Additional information is not expected as follow up information cannot be obtained.; Sender's Comments: US-009507513-1706USA010924: US-009507513-1706USA010923:
Temp 104.6, patient fussy, crying.  All follow up lab work negative, no other signs and symptomes.
pt inadvertantly recvd DTP 23NOV91; hospitalized 24 hrs & treated w/steroids; had inject site reaction erythema 4x2 cm w/pain; 25NOV mom reported that rt leg DTP was 1 1/2" larger than lt leg; had red knots/lumps; c/o back pain; pain;
I didn't have a reaction to the vaccine - only caught COVID after two vaccines and two boosters.
Swelling and redness in area of vaccination -  about 4" around, pain in arm.
Abnormal Menstruation cycles for the five cycles following the vaccine.  Menstruation has been irregular (beginning 3-5 days late) and lighter flow than usual in the five months since receiving the first vaccination on 4/22/21 and continued after this second vaccination.  Increased, more than usual, fatigue and cramping during menstruation.  Persistent fever, body aches and weakness in the two days following this vaccination. Treated with Tylenol.
FLU LIKE SYMPTOMS; STOMACH ISSUES; BODY ACHES; LOSS OF APPETITE; FELT AWFUL; CHILLS; LOST OF TASTE BUDS; METALLIC TASTE; INJECTION SITE PAIN; FEVER; ARM STARTED TO HURT; LIPS BURNING; This spontaneous report received from a patient concerned a 67 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included steroid allergy, sulfa drugs allergy, allergic to metals, some other seasonal allergies, cancer, lyme disease, and disability in the foot, and other pre-existing medical conditions included patient was allergic to spine injection. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 206A2A, and expiry: UNKNOWN) dose was not reported, administered on 28-APR-2021 for prophylactic vaccination. Concomitant medications included codeine, ibuprofen, and paracetamol. On 29-APR-2021, the subject experienced lips burning. On 29-APR-2021, the subject experienced arm started to hurt. On 29-APR-2021, the subject experienced injection site pain. On 29-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100 F. On 09-MAY-2021, the subject experienced lost of taste buds. On 09-MAY-2021, the subject experienced metallic taste. On 10-MAY-2021, the subject experienced flu like symptoms. On 10-MAY-2021, the subject experienced stomach issues. On 10-MAY-2021, the subject experienced body aches. On 10-MAY-2021, the subject experienced loss of appetite. On 10-MAY-2021, the subject experienced felt awful. On 10-MAY-2021, the subject experienced chills. On 11-MAY-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative, and Influenza virus test (NR: not provided) Negative. The action taken with covid-19 vaccine was not applicable. The patient recovered from lips burning, and injection site pain on 2021, was recovering from fever, chills, flu like symptoms, stomach issues, body aches, loss of appetite, felt awful, and arm started to hurt, and had not recovered from lost of taste buds, and metallic taste. This report was non-serious.
This spontaneous report was received  from a pharmacist refers to a patient of unknown  demographics .On unknown date, the patient was vaccinated with ZOSTAVAX dose 1, 0.65 ml (also reported as 19400 PFU (plaque-forming units), subcutaneously. On 08-OCT-2014, the patient received a second dose of ZOSTAVAX. No adverse effects were reported. No product quality complaint (PQC) was reported. Causality assessment was reported as not related to therapy with ZOSTAVAX. Additional information has been requested.
Information has been received from a physician concerning a 26 year old female with no known medical history or allergies who on 12-JUL-2007 was vaccinated with her first dose of Gardasil (lot # 657868/0523U).  On 07-SEP-2007 the patient was vaccinated with her second dose of Gardasil (lot # 657868/0523U).  On 04-JAN-2008 the patient was vaccinated with her third dose of Gardasil (lot # 659439/1267U).  The patient experienced nausea, dizziness and difficulty getting up and walking around for about a week after each dose.  The patient also experienced hip and joint pain for about a month after each dose.  The physician did some "autoimmune testing" and it all came back normal.  The patient was still under medical observation for the AE's.  She has not recovered.  The patient sought unspecified medical attention.  Additional information has been requested.
CHILLS, FEELING UNWELL, FEVER, HEADACHE, INJECTION SITE PAIN, INJECTION SITE REDNESS, INJECTION SITE SWELLING, JOINT PAIN, MUSCLE PAIN, NAUSEA, VOMITING, DIARRHEA, SWOLLEN LYMPH NODES AND TIREDNESS. HAVE RECOVED FROM MOST OF THESE SYMPTOMS BUT THE SWOLLEN LYMPH  NODES AS OF 1/12/20.
This spontaneous report as received from a health care worker (certified medical assistant) refers to a 5 year old male patient with none pertinent medical history and none drug reactions/allergies. On unknown date the patient was vaccinated with first dose of (Oka-Merck) PROQUAD (dose, lot # and expiration date not provided). On 21-JUL-2014 the patient was vaccinated with second 0.5 ml dose of expired PROQUAD (lot # J000199, exp. 08-JUL-2014) subcutaneously. There were none concomitant medication. Healthcare worker reported that patient's mother stated that on 21-JUL-2014 patient experienced a hard red knot at injection site with pain, swelling and a low grade temperature. TYLENOL and cold compressed was ordered as a treatment. There were no lab tests performed. The outcome of hard red knot at injection site with pain, swelling and a low grade temperature was unknown. Relatedness between events and (Oka-Merck) PROQUAD was not reported. Additional information has been requested.
1st dose 2018, 2nd dose 2019, mild outbreak 2021; Mild case of shingles; Rash; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In February 2019, the patient received the 2nd dose of Shingrix. In November 2018, the patient received the 1st dose of Shingrix. On an unknown date, more than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and rash. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and rash were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and rash to be related to Shingrix and Shingrix.  Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he received both doses of Shingrix and he developed a mild case of shingles in July or August 2021. The mild case of shingles was resolved. The patient stated that the rash from shingles lasted for 1 to 2 weeks, only. Very limited information was provided.  The consent to follow up was not asked. This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of shingles were not provided.
Patient received dose #1 of Moderna COVID-19  vaccine 2/13/2021. Family member reported patient death 3/12/2021
After recieving all three doses of Gardasil vaccine, had first ever Abnormal Pap.  All prior Pap's were normal.  Patient had no sexual contact over course of vaccines.
Red face, swollen Rt side face, headache Rt side face, and head, trouble swallowing Lft arm hurt. Lasted 3-5 days. Took allergy tablets, repeatedly 3-4 pill at a time.
Light headed; Nauseous; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed), NAUSEA (Nauseous) and MYALGIA (Body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (No reported medical history.).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headed), NAUSEA (Nauseous) and MYALGIA (Body aches). At the time of the report, DIZZINESS (Light headed), NAUSEA (Nauseous) and MYALGIA (Body aches) outcome was unknown.            Reporter did not allow further contact
glands underneath ears seem to be bothering me; head feels full/ seems to be all in my head; not feeling like myself; This spontaneous case was reported by a consumer and describes the occurrence of EAR DISCOMFORT (glands underneath ears seem to be bothering me), HEAD DISCOMFORT (head feels full/ seems to be all in my head) and FEELING ABNORMAL (not feeling like myself) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028220A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EAR DISCOMFORT (glands underneath ears seem to be bothering me), HEAD DISCOMFORT (head feels full/ seems to be all in my head) and FEELING ABNORMAL (not feeling like myself). At the time of the report, EAR DISCOMFORT (glands underneath ears seem to be bothering me), HEAD DISCOMFORT (head feels full/ seems to be all in my head) and FEELING ABNORMAL (not feeling like myself) outcome was unknown.            No relevant concomitant medications were reported by reporter It was reported that the patient wanted to get tested for COVID and was not sure if she had contracted COVID Treatment information was not provided by reporter
13:55 pt state having first dose covid vaccine allergic reaction with itchy and swelling in the throat. Currently, no sign of distress or pain. Pt state no allergic symptoms at this time.    14:05 pt state having itchiness in the throat but no swelling or difficulty breathing noted. No SOB or palpations. No sign of distress or pain. RN radio assistance and RN responded .      14:07 Discussed with pt to be transported to on site urgent care for further evaluations and treatment. Pt agreed to be transported to urgent care.    14:08 pt transported to urgent care accompany by RN. No sign of distress and in stable condition.
Fever of 102F and hives under left eye. Took ibuprofen and drank lots of water. Fever came down to 100F so I did not go to the hospital.
Excessive soreness at site and arm, slight swelling at site, chills hot and cold feeling overnight, headache morning after, flu like symptoms day after, aches, fatigue. Homecare and monitor, Tylenol 500mg, chicken soup, bottled water throughout the day, lemon ginger hot tea, essential oils, rest.